Genetic and epigenetic inactivation of TNFRSF10C in human prostate cancer

TNFRSF10C, is located on 8p21.3, one of the most frequently deleted loci in the genome of prostate cancer (PCa). Hypermethylation of TNFRSF10C promoter CpG island (CGI) had been reported in many tumors including PCa. However, the interplay between somatic deletion and promoter hypermethylation of TNFRSF10C on PCa development has not been investigated.

[1]  C. Taylor,et al.  Genetic and epigenetic analysis of von Hippel-Lindau (VHL) gene alterations and relationship with clinical variables in sporadic renal cancer. , 2006, Cancer research.

[2]  J. Rahnenführer,et al.  Protein phosphatase and TRAIL receptor genes as new candidate tumor genes on chromosome 8p in prostate cancer. , 2008, Cancer genomics & proteomics.

[3]  S. Hirohashi,et al.  Genomic loss and epigenetic silencing of very-low-density lipoprotein receptor involved in gastric carcinogenesis , 2006, Oncogene.

[4]  W. Isaacs,et al.  A novel role of myosin VI in human prostate cancer. , 2006, The American journal of pathology.

[5]  A. Gazdar,et al.  Methylation of apoptosis related genes in the pathogenesis and prognosis of prostate cancer. , 2006, Cancer letters.

[6]  J. Herman,et al.  Tumor-specific down-regulation of the tumor necrosis factor-related apoptosis-inducing ligand decoy receptors DcR1 and DcR2 is associated with dense promoter hypermethylation. , 2002, Cancer research.

[7]  S. Toyooka,et al.  Aberrant methylation of trail decoy receptor genes is frequent in multiple tumor types , 2004, International journal of cancer.

[8]  Jianfeng Xu,et al.  Comprehensive assessment of DNA copy number alterations in human prostate cancers using Affymetrix 100K SNP mapping array , 2006, Genes, chromosomes & cancer.

[9]  Thomas D. Schmittgen,et al.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. , 2001, Methods.

[10]  J. Neoptolemos,et al.  Two novel regions of interstitial deletion on chromosome 8p in colorectal cancer , 1999, Oncogene.

[11]  Jianfeng Xu,et al.  Deletion of a Small Consensus Region at 6q15, Including the MAP3K7 Gene, Is Significantly Associated with High-Grade Prostate Cancers , 2007, Clinical Cancer Research.

[12]  Juan F Medrano,et al.  Real-time PCR for mRNA quantitation. , 2005, BioTechniques.

[13]  Jianfeng Xu,et al.  Integration of somatic deletion analysis of prostate cancers and germline linkage analysis of prostate cancer families reveals two small consensus regions for prostate cancer genes at 8p. , 2007, Cancer research.

[14]  T. Murphy,et al.  The emergence of DNA methylation as a key modulator of aberrant cell death in prostate cancer. , 2008, Endocrine-related cancer.

[15]  C. Ren,et al.  Genetic and epigenetic alterations of LTF at 3p21.3 in nasopharyngeal carcinoma. , 2006, Oncology research.

[16]  K. Uzawa,et al.  Allelic loss on the short arm of chromosome 8 in oral squamous cell carcinoma. , 1999, Oncology Report.

[17]  J. Tschopp,et al.  TRAIL receptors 1 (DR4) and 2 (DR5) signal FADD-dependent apoptosis and activate NF-kappaB. , 1997, Immunity.

[18]  C. Ren,et al.  Genetic and epigenetic alterations of DLC-1, a candidate tumor suppressor gene, in nasopharyngeal carcinoma. , 2006, Acta biochimica et biophysica Sinica.

[19]  T. Guthrie,et al.  Prostate cancer. , 2020, American family physician.

[20]  S. Nomoto,et al.  Biallelic inactivation of the RIZ1 gene in human gastric cancer , 2003, Oncogene.

[21]  D. Birnbaum,et al.  Loss of heterozygosity at microsatellite markers from region p11-21 of chromosome 8 in microdissected breast tumor but not in peritumoral cells. , 2002, International journal of oncology.

[22]  Christoph Grunau,et al.  Identification and resolution of artifacts in bisulfite sequencing. , 2002, Methods.

[23]  D. White,et al.  Rel/NF-kappaB/IkappaB proteins and cancer. , 1996, Oncogene.

[24]  M. Rubin,et al.  Haploinsufficiency and reduced expression of genes localized to the 8p chromosomal region in human prostate tumors , 2003 .

[25]  J. Minna,et al.  Allelic losses at chromosome 8p21-23 are early and frequent events in the pathogenesis of lung cancer. , 1999, Cancer research.

[26]  P. Walsh,et al.  Homozygous deletion and frequent allelic loss of chromosome 8p22 loci in human prostate cancer. , 1993, Cancer research.

[27]  M. Knowles,et al.  Loss of heterozygosity analysis and DNA copy number measurement on 8p in bladder cancer reveals two mechanisms of allelic loss. , 2005, Cancer research.

[28]  J. Grill,et al.  Methylation of RASSF1A and TRAIL pathway-related genes is frequent in childhood intracranial ependymomas and benign choroid plexus papilloma. , 2006, Cancer genetics and cytogenetics.

[29]  Jin Woo Kim,et al.  DNA copy number alterations in prostate cancers: A combined analysis of published CGH studies , 2007, The Prostate.

[30]  L. Hood,et al.  Death receptor 5, a new member of the TNFR family, and DR4 induce FADD-dependent apoptosis and activate the NF-kappaB pathway. , 1997, Immunity.

[31]  O. Olopade,et al.  BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. , 2005, Cancer research.

[32]  E. Dirice,et al.  Surface TRAIL decoy receptor-4 expression is correlated with TRAIL resistance in MCF7 breast cancer cells , 2005, BMC Cancer.